Request a timeline for reassessing semaglutide effectiveness after 12 weeks, with clear metrics for continuing, adjusting, or pausing therapy
Personalizing GLP-1 Treatment: Genetic Insights Into Stress Pathways PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and examines genetic variants that influence how individuals respond to GLP-1 agonists and manage stress hormones
Step 2 Clinician Review Your provider reviews your chart and creates a personalized treatment plan with the right medication, dose, and support
cDNA synthesis was performed using the QuantiTect Reverse Transcription kit (Qiagen) or the High-Capacity cDNA Reverse Transcription kit (Thermo Fisher Scientific), according to the manufacturers instructions
MS/MS of modified rat MGST1 peptide, VFANPEDC * AGFGK, was confirmed by comparison to previously analyzed standard peptide (Golizeh et al., Table 5
This is a clinician-oriented comparison of what these three peptides do and who each one fits